Based on these results we can conclude that clinico-pathological characteristics of the tumour might indeed play a confounding or mediating role in the association between BRCA1/2 mutation carriership and breast cancer survival, though more research should be performed to further elucidate this. The gene discussed is BRCA1; the disease is breast carcinoma.